Skip to main content Skip to main navigation menu Skip to site footer

Frequency of Interleukin-6 rs 1800796 (-572G/C) and 2069837 (intron 2A/G), TNF-α rs1800750 (-376G/A), and 1800629 (-308G/A) polymorphism in COVID-19 patients with clinical degrees in Central Java

  • Reviono ,
  • Hendrastutik ,
  • Yulia Sari ,
  • Betty Suryawati ,
  • Darmawan ismail ,
  • Ketut Putu Yasa ,


Background: Coronavirus Disease 2019 (COVID-19) is an easily contagious disease, and not much is known about the characteristics of COVID-19, both in terms of susceptibility, severity, and spreadability of various SARS-CoV-2 strains. Patient genomic factors, especially related to genomic polymorphisms that affect the body's immune system, can influence the course of infectious diseases. The aim of this study is to get an adequate picture regarding gene polymorphisms, both susceptibility and related to the clinical degree in COVID-19 patients.

Methods: The PCR preparations were carried out in the Biomedical laboratory of the Faculty of Medicine, Universitas Sebelas Maret. The qualitative PCR (qPCR) examination was sent to the Genetica Science laboratory, Tangerang, West Java. The research subjects were divided into 3 groups, namely COVID-19 patients with no symptoms, COVID-19 patients with mild-moderate symptoms, COVID-19 patients with severe-critical symptoms. The research subjects were taken 6 cc of venous blood (3 cc for examination of serum IL-6 and TNFα levels and 3 cc for DNA examination).

Results: Serum levels of IL-6 and TNF-α in the clinical grade group were almost all above normal values. The frequency of TNF- α polymorphisms (-376G/A) all showed homozygote GG. TNF-α (-308G/A) also showed homozygote GG was dominant for SARS CoV2. IL-6 (-572G/C) polymorphism for cases requiring medium and severe clinical degree hospitalization was found to have more C allele than G allele. IL-6 polymorphism (intron A/G) the G allele is less common in cases requiring hospitalization.

Conclusion: TNF-α(−308A) allele has an influence on the development of clinical symptoms of SARS CoV2 infection. The rs1800796GG genotype in the IL-6 promoter contributes to milder symptoms in SARS CoV2 infection. Allelic variants of the gene under study may show different effects in other races depending on their interactions with other risk factors.


  1. Yang L, Liu S, Liu J, et al. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther. 2020;5(1):128. doi:10.1038/s41392-020-00243-2.
  2. Benetti E, Tita R, Spiga O, et al. ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population. Eur J Hum Genet. 2020;28(11):1602-1614. doi:10.1038/s41431-020-0691-z.
  3. Mangalmurti N, Hunter CA. Cytokine Storms: Understanding COVID-19. Immunity. 2020;53(1):19-25. doi:10.1016/j.immuni.2020.06.017.
  4. Saleh A, Sultan A, Elashry MA, et al. Association of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients. Immunol Invest. 2022;51(3):546-557. doi:10.1080/08820139.2020.1851709.
  5. Sotomayor-Lugo F, Alemañy-Díaz Perera C, Roblejo-Balbuena H, et al. The role of tumor necrosis factor alpha − 308A > G polymorphism on the clinical states of SARS-CoV-2 infection. The Egyptian Journal of Medical Human Genetics. 2022;23(1):55. doi:10.1186/s43042-022-00274-0.
  6. Zhang G, Zhou B, Wang W, et al. A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis. 2012;205(11):1697-1704. doi:10.1093/infdis/jis266.
  7. Wang Z, Wu S, Liao J, et al. Interleukin-6 and rs1800796 locus single nucleotide polymorphisms in response to hypoxia/reoxygenation in hepatocytes. Int J Mol Med. 2016;38(1):192-200. doi:10.3892/ijmm.2016.2595.
  8. Gong B, Huang L, He Y, et al. A genetic variant in IL-6 lowering its expression is protective for critical patients with COVID-19. Signal Transduct Target Ther. 2022;7(1). doi:10.1038/s41392-022-00923-1.
  9. Patel J, Matalon R, Sangeeta N, Chonmaitree T. Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media. Pediatrics. 2006;118(6):2273-2279. doi:10.1542/peds.2006-0764.
  10. Revai K, Patel JA, Grady JJ, Nair S, Matalon R, Chonmaitree T. Association between cytokine gene polymorphisms and risk for upper respiratory tract infection and acute otitis media. Clin Infect Dis. 2009;49(2):257-261. doi:10.1086/599833.
  11. Li G, Wu W, Zhang X, et al. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity. BMC Nephrol. 2018;19(1):1-9. doi:10.1186/s12882-018-1069-0.
  12. Kerget F, Kerget B. Frequency of Interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) Polymorphisms in COVID-19 Patients in Turkey Who Develop Macrophage Activation Syndrome. Jpn J Infect Dis. 2021;74(6):543-548. doi:10.7883/yoken.JJID.2021.046.
  13. Gorham J, Moreau A, Corazza F, et al. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis. PLoS One. 2020;15(12):e0244628. Published 2020 Dec 31. doi:10.1371/journal.pone.0244628.

How to Cite

Reviono, Hendrastutik, Yulia Sari, Betty Suryawati, Darmawan ismail, & Ketut Putu Yasa. (2022). Frequency of Interleukin-6 rs 1800796 (-572G/C) and 2069837 (intron 2A/G), TNF-α rs1800750 (-376G/A), and 1800629 (-308G/A) polymorphism in COVID-19 patients with clinical degrees in Central Java. Bali Medical Journal, 11(3), 1364–1368.